SEMA4D and glioblastoma: As concerning class-4 semaphorins, indirect experimental evidence suggested the involvement of Sema4D in GBM progression, as a stable silencing of its receptor, Plexin-B1, in human U87MG and U251 GBM cells significantly increased apoptotic death.